Status:
UNKNOWN
KEEP Intervention for People Newly Diagnosed With Parkinson's
Lead Sponsor:
University of Cambridge
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Parkinson's Disease (PD) is a progressive neurological condition that affects movement, balance and cognition, resulting in loss of independence and compromised quality of life over the course of the ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Idiopathic Parkinson's Disease
- Within 12 months since diagnosis
- Stable medication regime for four weeks prior to initiation of trial
- Ability to understand written English
Exclusion
- Acute illness
- History of neurological disorder other than Parkinson Disease
- Diagnosis of dementia or significant cognitive impairments
- Participation in NHS structured PD-specific education program with or without exercise classes in the last year
- Unable to understand written English
Key Trial Info
Start Date :
June 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 18 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05253040
Start Date
June 18 2022
End Date
June 18 2023
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry
Cambridge, United Kingdom, CB2 0SZ